Pacer Advisors Inc. Invests $593,000 in Option Care Health, Inc. $OPCH

Pacer Advisors Inc. purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH) during the 3rd quarter, HoldingsChannel reports. The fund purchased 21,370 shares of the company’s stock, valued at approximately $593,000.

Other large investors have also recently bought and sold shares of the company. Durable Capital Partners LP lifted its holdings in shares of Option Care Health by 134.2% during the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock valued at $267,557,000 after acquiring an additional 4,720,988 shares during the period. Norges Bank bought a new stake in shares of Option Care Health in the 2nd quarter worth about $69,932,000. Swedbank AB acquired a new stake in shares of Option Care Health during the 3rd quarter worth about $49,455,000. Arrowstreet Capital Limited Partnership increased its position in shares of Option Care Health by 109.0% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company’s stock worth $110,770,000 after purchasing an additional 1,778,279 shares in the last quarter. Finally, Jennison Associates LLC lifted its holdings in Option Care Health by 145.6% during the 2nd quarter. Jennison Associates LLC now owns 2,138,248 shares of the company’s stock valued at $69,450,000 after purchasing an additional 1,267,660 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Stock Performance

Shares of Option Care Health stock opened at $32.24 on Friday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.56 and a quick ratio of 1.05. The firm has a 50 day simple moving average of $30.23 and a 200 day simple moving average of $29.39. Option Care Health, Inc. has a fifty-two week low of $22.62 and a fifty-two week high of $35.53. The firm has a market cap of $5.12 billion, a P/E ratio of 25.59, a P/E/G ratio of 2.01 and a beta of 0.80.

Wall Street Analyst Weigh In

Several analysts have weighed in on the stock. JMP Securities set a $36.00 price objective on shares of Option Care Health in a research note on Friday, October 31st. Citizens Jmp reduced their target price on Option Care Health from $38.00 to $36.00 and set a “market outperform” rating on the stock in a report on Friday, October 31st. Wall Street Zen cut Option Care Health from a “buy” rating to a “hold” rating in a report on Sunday, December 14th. Cowen started coverage on Option Care Health in a research report on Thursday, October 2nd. They issued a “hold” rating for the company. Finally, Barrington Research reissued an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Friday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $36.27.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of the stock in a transaction dated Monday, November 3rd. The stock was bought at an average cost of $25.98 per share, with a total value of $987,240.00. Following the purchase, the director owned 413,390 shares of the company’s stock, valued at approximately $10,739,872.20. This represents a 10.12% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.